Latin America Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases), By Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR And Gene Sequencing) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Latin America Companion Diagnostics Market By Indication (Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, And Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases), By Technology (Immunohistochemistry, Molecular Diagnostics (In-Situ Hybridization, Real Time PCR And Gene Sequencing) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 644 | Pages: 145 | October 2018 | Region: Latin America


Latin America Companion Diagnostics Market was worth USD0.27 million in 2018 and estimated to be growing at a CAGR of 22.83%, to reach USD 0.74 million by 2023. Increased adoption of innovative medical procedures, the rising disposable incomes of consumers, and the rising healthcare infrastructure will fuel the Latin America companion diagnostics market.

Companion diagnostics are in-vitro diagnostics that deliver information about therapeutic reactions of patients for a specific treatment. Companion diagnostics is a comparatively new branch of diagnostics that is predicted to grow at a rapid pace in the near future. The various advantages it offers have increased its market demand.

Increasing demand for personalized medicines, rising occurrence of cancer and reducing costs of drug development are the key factors fuelling the growth of the market for companion diagnostics. Factors such as the growing emphasis on targeted therapies and the attention of pharmaceutical companies on the in-house development of companion diagnostics are also enhancing the growth of the market. Increasing period of the approval process and the extended development time of companion diagnostics may obstruct the growth of the market.

The Latin America clinical nutrition market is segmented on the basis of indication into Oncology (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer), Cardiovascular Diseases, Central Nervous System Disorders, Inflammation and Virology Diseases. Further, Oncology is sub-segmented as Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, and Gastric Cancer. Oncology being the highest revenue creating segment as most of the companion diagnostics has been developed to detect one or the other cancer biomarkers. On the basis of technology, the market is bifurcated into Immunohistochemistry and molecular diagnostics. Molecular diagnostics is segmented into in-situ hybridization, real time PCR and gene sequencing.

Based on geography the Latin America market is analysed under various regions namely, Mexico, Brazil and Argentina. Mexico dominates the Latin America Companion Diagnostics market and is estimated to continue its dominance over the forecast period.

Some of the key participating global players in companion diagnostics market global market are Abbott Molecular Inc., Roche Molecular Systems Inc., Leica Biosystems Nussloch GmbH, bioMérieux Inc., Dako Inc., Qiagen Ltd., ARUP Laboratories, Myriad Genetics Inc.,Biogenex Laboratories Inc., Ventana Medical Systems Inc., Thermo Fisher Scientific Inc. and others.

  1. 1. Introduction                                 

                    1.1 Market Definition                    

                    1.2 Study Deliverables                  

                    1.3 Base Currency, Base Year and Forecast Periods                          

                    1.4 General Study Assumptions                

    2. Research Methodology                                           

                    2.1 Introduction                               

                    2.2 Research Phases                      

                                    2.2.1 Secondary Research           

                                    2.2.2 Primary Research 

                                    2.2.3 Econometric Modelling      

                                    2.2.4 Expert Validation  

                    2.3 Analysis Design                         

                    2.4 Study Timeline                          

    3. Overview                                       

                    3.1 Executive Summary                

                    3.2 Key Inferences                         

                    3.3 New Developments                               

    4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                    4.1 Market Drivers                          

                    4.2 Market Restraints                    

                    4.3 Key Challenges                         

                    4.4 Current Opportunities in the Market                              

    5. Market Segmentation                                              

                    5.1 By Indications                            

                                    5.1.1 Oncology 

                                                    5.1.1.1 Colorectal Cancer

                                                    5.1.1.2 Breast Cancer

                                                    5.1.1.3 Lung Cancer

                                                    5.1.1.4 Gastric Cancer

                                                    5.1.1.5 Melanoma

                                    5.1.2 Inflammation and Autoimmune Diseases  

                                    5.1.3 Cardiovascular Diseases    

                                    5.1.4 Central Nervous System Disorders               

                                    5.1.5 Virology Diseases 

                    5.2 By Technology                           

                                    5.2.1 Immuno Histochemistry    

                                    5.2.2 Molecular Diagnostics        

                                                    5.2.2.1 In-Situ Hybridization

                                                    5.2.2.2 Real Time PCR

                                                    5.2.2.3 Gene Sequencing

    6. Geographical Analysis                                              

                                    6.1 Introduction               

                                    6.2 Brazil             

                                    6.3 Mexico         

                                    6.4 Argentina    

                                    6.5 Rest of Latin America             

    7. Strategic Analysis                                       

                    7.1 PESTLE analysis                         

                                    7.1.1 Political     

                                    7.1.2 Economic 

                                    7.1.3 Social         

                                    7.1.4 Technological         

                                    7.1.5 Legal          

                                    7.1.6 Environmental       

                    7.2 Porter’s Five analysis                              

                                    7.2.1 Bargaining Power of Suppliers        

                                    7.2.2 Bargaining Power of Consumers    

                                    7.2.3 Threat of New Entrants     

                                    7.2.4 Threat of Substitute Products and Services              

                                    7.2.5 Competitive Rivalry within the Industry     

    8. Market Leaders' Analysis                                        

                    8.1 Abbott Molecular Inc.                            

                                    8.1.1 Overview 

                                    8.1.2 Product Analysis   

                                    8.1.3 Strategic Evaluation and Operations            

                                    8.1.4 Financial analysis  

                                    8.1.5 Legal issues             

                                    8.1.6 Recent Developments       

                                    8.1.7 SWOT analysis       

                                    8.1.8 Analyst View          

                    8.2 Roche Molecular Systems Inc.                            

                    8.3 Leica Biosystems Nussloch GmbH                     

                    8.4 BioMérieux Inc.                        

                    8.5 Dako Inc.                     

                    8.6 Qiagen Ltd.                 

                    8.7 ARUP Laboratories                  

                    8.8 Myriad Genetics Inc.                              

                    8.9 Biogenex Laboratories, Inc.                 

                    8.10 Ventana Medical Systems Inc.                         

                    8.11 Thermo Fisher Scientific Inc.                             

    9. Competitive Landscape                                           

                    9.1 Market share analysis                            

                    9.2 Merger and Acquisition Analysis                       

                    9.3 Agreements, collaborations and Joint Ventures                         

                    9.4 New Product Launches                         

    10. Expert Opinions                                        

                    10.1 Market Outlook                     

                    10.2 Investment Opportunities                 

    Appendix                                           

                    a) List of Tables                

                    b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Companion Diagnostics Market By Region, From 2018-2023 (USD million)
  2. Latin America Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  3. Latin America Oncology Market By Region, From 2018-2023 (USD million)
  4. Latin America Inflammation and Autoimmune Diseases Market By Region, From 2018-2023 (USD million)
  5. Latin America Cardiovascular Diseases Market By Region, From 2018-2023 (USD million)
  6. Latin America Central Nervous System Disorders Market By Region, From 2018-2023 (USD million)
  7. Latin America Virology Diseases Market By Region, From 2018-2023 (USD million)
  8. Latin America Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  9. Latin America Immuno Histochemistry Market By Region, From 2018-2023 (USD million)
  10. Latin America Molecular Diagnostics Market By Region, From 2018-2023 (USD million)
  11. Latin America Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  12. Latin America Colorectal Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  13. Latin America Breast Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  14. Latin America Lung Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  15. Latin America Gastric Cancer Diagnostics Market By Region, From 2018-2023 (USD million)
  16. Latin America Melanoma Diagnostics Market By Region, From 2018-2023 (USD million)
  17. Latin America Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  18. Latin America In-Situ Hybridization Market By Region, From 2018-2023 (USD million)
  19. Latin America Real Time PCR Market By Region, From 2018-2023 (USD million)
  20. Latin America Gene Sequencing Market By Region, From 2018-2023 (USD million)
  21. Brazil Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  22. Brazil Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  23. Brazil Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  24. Brazil Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  25. Argentina Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  26. Argentina Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  27. Argentina Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  28. Argentina Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
  29. Mexico Companion Diagnostics Market By Indication, From 2018-2023 (USD million)
  30. Mexico Companion Diagnostics Market By Technology, From 2018-2023 (USD million)
  31. Mexico Oncology Diagnostics Market By Type, From 2018-2023 (USD million)
  32. Mexico Molecular Diagnostics Market By Type, From 2018-2023 (USD million)
Middle East And Africa Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Ov...
Latin America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Asia-pacific Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive B...
Europe Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder...
North America Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive ...
Overactive Bladder Treatment Market By Treatment (Mirabegron, Anticholinergics, Botox, Intravesical Instillation And Neurostimulation), By Disease (Neurogenic Overactive Bladder, Idiopathic Overactive Bladder) And B...
Middle East And Africa Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Lab...
Latin America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories...
Asia-Pacific Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories,...
Europe Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospital Laboratories, Refer...
North-America Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (Culture-based, PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia), End User (Hospit...
Blood Culture Tests Market By Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), And Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-202...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.